...
首页> 外文期刊>Contraception >A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel
【24h】

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel

机译:单臂研究,评估左炔诺孕酮对肛周口服避孕药的疗效,安全性和可接受性

获取原文
获取原文并翻译 | 示例

摘要

Background An oral dose of 0.75 mg levonorgestrel (LNG) taken shortly after sex was marketed as a routine, nonemergency contraceptive method until the 1990s. Because a hormonal method used only at the time of intercourse may be desirable for women who have infrequent sex, we conducted a study to reevaluate the potential of pericoital LNG as a primary means of contraception. Methods We enrolled women aged 18-45 years in Brazil and the USA who expected to have sex 1-4 days per month for 6.5 months. Participants were instructed to take one tablet 0.75 mg LNG within 24 h before or after sex, with no more than one dose in any 24-h period. The primary efficacy measure was the Pearl Index among women aged 18-35 years. Results The study was stopped after 72 of the planned 300 participants were enrolled due to slow recruitment and related feasibility considerations. In the primary analysis, three pregnancies occurred during 13.4 woman-years of follow-up, resulting in a Pearl Index of 22.4 (95% confidence interval, 4.6-65.4). No serious adverse events were reported, and vaginal bleeding patterns were generally acceptable. Conclusions Our estimated Pearl Index was noticeably higher than expected from previous research of LNG for pericoital contraception. Although the regimen was safe and generally acceptable, the study was challenged by slow enrollment and curtailed person-years of follow-up, resulting in poor precision for the estimated treatment effect. Future research may inform whether our results are symptomatic of the regimen, study design or characteristics of the populations from which we recruited. Implications Our study failed to confirm prior data suggesting that 0.75 mg LNG for pericoital contraception could be more effective than typical use of barrier methods among women having infrequent sex. Characterizing populations most likely to adhere to, and benefit from, pericoital regimens is essential to future research on these methods.
机译:背景技术直到1990年代,性交后不久就以0.75 mg左炔诺孕酮(LNG)口服作为常规的非紧急避孕方法上市。由于性交频率低的女性可能只希望在性交时使用激素方法,因此我们进行了一项研究,以重新评估会阴LNG作为主要避孕手段的潜​​力。方法我们在巴西和美国纳入了18-45岁的女性,这些女性预期每月1-4天做爱6.5个月。指示参与者在性爱前后24小时内服用一粒0.75 mg LNG片剂,在任何24小时内均不超过一剂。主要功效指标是18-35岁女性的Pearl指数。结果由于缓慢的招募和相关的可行性考虑,在计划的300名参与者中有72名被纳入后,该研究被终止。在初步分析中,在13.4妇女年的随访期间发生了3次怀孕,珍珠指数为22.4(95%置信区间为4.6-65.4)。没有严重的不良反应的报道,阴道出血的形式通常是可以接受的。结论我们估计的Pearl指数明显高于以前的LNG围产期避孕研究的预期。尽管该方案是安全的并且通常可以接受,但是该研究面临入选缓慢和随访人年减少的挑战,从而导致估计治疗效果的准确性较差。未来的研究可能会告诉我们我们的结果是否是我们所招募人群的治疗方案,研究设计或特征的征兆。启示我们的研究未能证实以前的数据,即在不频繁发生性行为的女性中,使用0.75 mg LNG进行周膜避孕可能比使用屏障方法更有效。表征最有可能遵守和受益于肛周治疗方案的人群对于这些方法的未来研究至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号